Comparative effectiveness of long-acting injectable antipsychotics in a large naturalistic cohort across two European centers: Findings from the long-acting injectable antipsychotics collaborative (LAICO) study.-Reference-Cited by-同舟云学术

Comparative effectiveness of long-acting injectable antipsychotics in a large naturalistic cohort across two European centers: Findings from the long-acting injectable antipsychotics collaborative (LAICO) study.

Published:2022 Issue: Volume:1 Page:100111
ISSN:2772-4085
Container-title:Neuroscience Applied
language:en
Short-container-title:Neuroscience Applied

Author:

García-Carmona Juan Antonio^ORCID,Barnett Joshua^ORCID,Campos-Navarro María Pilar^ORCID,Mason Katy^ORCID,Valdivia-Muñoz Francisco,Pappa Sofia^ORCID

Funder

Servicio Murciano de Salud

Publisher

Elsevier BV

Reference57 articles.

1. Off-label use of second-generation antipsychotics in borderline personality disoder: a survey of Italian psychiatrists;Aguglia;J. Pers. Disord.,2019

2. Schizophrenia, “just the facts”: what we know in 2008 part 1: overview;Andon;Schizophr. Res.,2008

3. STAR netweork depot investigators;Bartoli;Psychatry Res,2022

4. Paliperidone palmitate once-every-3-months in adults with early illess schizophrenia;Bell Lynum;Early Int Psychiatry,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multicenter, 4-year mirror-image study comparing the effectiveness of long- acting injectable antipsychotics in the treatment of Bipolar Disorder: Results from the LAICO study;2024-08-09

2. Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal;Drug, Healthcare and Patient Safety;2023-09

3. Switching from Monthly to Three-Monthly Long-Acting Injectable Paliperidone: A Survey on Subjective Satisfaction and Safety;Patient Preference and Adherence;2023-07

4. Preliminary data from a 4-year mirror-image and multicentre study of patients initiating paliperidone palmitate 6-monthly long-acting injectable antipsychotic: the Paliperidone 2 per Year study;Therapeutic Advances in Psychopharmacology;2023-01

5. Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies;Therapeutic Advances in Psychopharmacology;2023-01